Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lamb

Showing results (51-60 of 489) with videos related to

Pageof 49
Sort By:
Drugs & Aging|May 10, 2000
Donepezil: a review of its use in Alzheimer's diseaseM Dooley, H M Lamb
Drugs & Aging|November 14, 1997
Samarium 153Sm lexidronamH M Lamb, D Faulds
Drugs & Aging|December 31, 1997
MetrifonateH M Lamb, D Faulds
Drugs|November 7, 1998
RifapentineB Jarvis, H M Lamb
Journal of Intellectual Disability Research : JIDR|January 5, 2008
Interviewing alleged victims with intellectual disabilitiesA-C Cederborg, M Lamb
Journal of the American Chemical Society|May 21, 2011
Redox-switchable surface for controlling peptide structureBrian M Lamb, Muhammad N Yousaf
Drugs|March 16, 2000
Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infectionsJ A Balfour, H M Lamb
Drugs & Aging|August 25, 1999
ValrubicinS V Onrust, H M Lamb
Pharmacoeconomics|October 4, 1997
Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in womenA P Lea, H M Lamb
Progress in Clinical and Biological Research|January 1, 1982
Differential accumulation and aggregation of proteoglycans in limb developmentN S Vasan, K M Lamb
Pageof 49

Showing results (51-60 of 489) with videos related to

Sort By:
Pageof 49
Drugs & Aging|May 10, 2000
Donepezil: a review of its use in Alzheimer's diseaseM Dooley, H M Lamb
Drugs & Aging|November 14, 1997
Samarium 153Sm lexidronamH M Lamb, D Faulds
Drugs & Aging|December 31, 1997
MetrifonateH M Lamb, D Faulds
Drugs|November 7, 1998
RifapentineB Jarvis, H M Lamb
Journal of Intellectual Disability Research : JIDR|January 5, 2008
Interviewing alleged victims with intellectual disabilitiesA-C Cederborg, M Lamb
Journal of the American Chemical Society|May 21, 2011
Redox-switchable surface for controlling peptide structureBrian M Lamb, Muhammad N Yousaf
Drugs|March 16, 2000
Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infectionsJ A Balfour, H M Lamb
Drugs & Aging|August 25, 1999
ValrubicinS V Onrust, H M Lamb
Pharmacoeconomics|October 4, 1997
Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in womenA P Lea, H M Lamb
Progress in Clinical and Biological Research|January 1, 1982
Differential accumulation and aggregation of proteoglycans in limb developmentN S Vasan, K M Lamb
Pageof 49